Lyell Immunopharma, Inc.
LYEL
$10.64
-$0.33-3.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -43.64% | -42.77% | -32.17% | -23.44% | -17.56% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -37.69% | 1.73% | 7.14% | -16.85% | -18.35% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -43.54% | -42.12% | -31.57% | -23.31% | -17.58% |
|
|
|||||
| Total Current Assets | -43.54% | -42.12% | -31.57% | -23.31% | -17.58% |
| Net Property, Plant & Equipment | -54.08% | -50.37% | -48.75% | -16.13% | -15.72% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -9.10% | 8.44% | 39.68% | 13.66% | -5.75% |
| Total Assets | -41.08% | -38.09% | -34.55% | -22.11% | -21.69% |
|
|
|||||
| Total Accounts Payable | -19.53% | -23.84% | 11.40% | -17.62% | -27.67% |
| Total Accrued Expenses | 3.82% | 25.66% | 44.23% | -7.27% | -1.09% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 23.37% | 23.56% | 27.12% | 17.70% | 17.85% |
| Total Finance Division Other Current Liabilities | 447.03% | 151.14% | 261.09% | -13.37% | -73.09% |
| Total Other Current Liabilities | 447.03% | 151.14% | 261.09% | -13.37% | -73.09% |
| Total Current Liabilities | 19.51% | 27.61% | 55.82% | -4.43% | -10.21% |
|
|
|||||
| Total Current Liabilities | 19.51% | 27.61% | 55.82% | -4.43% | -10.21% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -12.61% | -11.44% | -10.37% | -12.18% | -11.45% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -11.89% | -11.55% | -11.22% | -5.59% | -11.55% |
| Total Liabilities | -1.27% | 2.43% | 13.63% | -9.13% | -11.02% |
|
|
|||||
| Common Stock & APIC | 3.78% | 4.04% | 4.25% | 2.13% | 2.32% |
| Retained Earnings | -29.89% | -31.48% | -34.23% | -21.49% | -23.41% |
| Treasury Stock & Other | 114.36% | 139.11% | 409.57% | 164.35% | 83.31% |
| Total Common Equity | -47.23% | -44.21% | -41.55% | -23.92% | -23.12% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -47.23% | -44.21% | -41.55% | -23.92% | -23.12% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -47.23% | -44.21% | -41.55% | -23.92% | -23.12% |
|
|
|||||